WAA, F., A, E., AHA, A., DME, A., HK, A., HH, H., . . . MTM, N. (2026). Novel pyrazole carboxylate derivatives as lonazolac bioisosteres with selective COX-2 inhibition: Design, synthesis and anti-inflammatory activity. Molecular diversity, 30(1), 933. https://doi.org/10.1007/s11030-025-11220-8
Chicago Style (17th ed.) CitationWAA, Fadaly, Elshewy A, Abusabaa AHA, Amin DME, Abdelhady HK, Haredy HH, Mahmoud AM, Ibrahim NA, and Nemr MTM. "Novel Pyrazole Carboxylate Derivatives as Lonazolac Bioisosteres with Selective COX-2 Inhibition: Design, Synthesis and Anti-inflammatory Activity." Molecular Diversity 30, no. 1 (2026): 933. https://doi.org/10.1007/s11030-025-11220-8.
MLA (9th ed.) CitationWAA, Fadaly, et al. "Novel Pyrazole Carboxylate Derivatives as Lonazolac Bioisosteres with Selective COX-2 Inhibition: Design, Synthesis and Anti-inflammatory Activity." Molecular Diversity, vol. 30, no. 1, 2026, p. 933, https://doi.org/10.1007/s11030-025-11220-8.
